G
Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
NSE:GLS
Price:
836.25 INR
0.63%
Market Closed
Updated:
Jun 1, 2024
Glenmark Life Sciences Ltd
Other Long-Term Assets
|
Glenmark Life Sciences Ltd
Other Long-Term Assets Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Other Long-Term Assets
₹12.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Other Long-Term Assets
₹12B
|
CAGR 3-Years
3%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Other Long-Term Assets
₹8.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
23%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Other Long-Term Assets
₹36.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
12%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Other Long-Term Assets
₹18.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Other Long-Term Assets
₹6.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
5%
|
CAGR 10-Years
19%
|
See Also
What is Glenmark Life Sciences Ltd's Other Long-Term Assets?
Other Long-Term Assets
12.7m
INR
12.7m
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Other Long-Term Assets amounts to 12.7m INR.
What is Glenmark Life Sciences Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
-31%
-31%
Over the last year, the Other Long-Term Assets growth was 0%. The average annual Other Long-Term Assets growth rates for Glenmark Life Sciences Ltd have been -2% over the past three years , -31% over the past five years .
You don't have any saved screeners yet
